Related Experiment Videos
Solid tumor treatment workshop summary
1University of Southern California, School of Medicine, Department of Internal Medicine, Los Angeles.
Abstract:
Retinoic acids exert a wide range of biological activities following binding to the cognate nuclear receptors, which has several members (RAR-alpha, beta, gamma and RXR-alpha, beta, gamma). Retinoic acids lead to several different effects on tumor cells and include cell differentiation, inhibition of cell proliferation and apoptosis. The expression and abundance of each receptor type, and the distinct role of each receptor type related to biologic effect is under investigation. Similarly the mechanism(s) responsible for favorable responses in certain tumor types (skin, cervical) needs to be understood to best utilize this family of compounds, either alone or in various combinations. The significancer of drug-drug interaction in regard to their effects on pharmacokinetics, receptor modulation and regulation of cytoplasmic retinoic acid receptor binding proteins (CRABPs) should be carefully evaluated in pre-clinical and clinical trials. Furthermore, appropriate models to study combinations of RAs with other biological response modifiers are needed.
Insights
Retinoic acids (RAs) impact tumor cells via nuclear receptors, influencing differentiation, proliferation, and apoptosis. Further research is needed to understand receptor roles and optimize RA combination therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Retinoic acids (RAs) exhibit diverse biological activities by interacting with nuclear receptors, including RARs and RXRs.
- RAs induce significant effects on tumor cells, such as promoting cell differentiation, inhibiting proliferation, and triggering apoptosis.
Framework:
- The precise roles and expression patterns of individual retinoic acid receptor subtypes (RAR-alpha, beta, gamma; RXR-alpha, beta, gamma) are under active investigation.
- Understanding the mechanisms behind RA efficacy in specific cancers like skin and cervical cancer is crucial for optimizing their therapeutic use.
Implementation:
- Investigating drug-drug interactions is vital, focusing on pharmacokinetic changes, receptor modulation, and the regulation of cytoplasmic retinoic acid-binding proteins (CRABPs).
- Pre-clinical and clinical trials must carefully evaluate these interactions to ensure safe and effective RA-based treatments.
Implications:
- Developing appropriate models is essential for studying combinations of RAs with other biological response modifiers.
- This research aims to enhance the clinical utility of retinoic acids in cancer therapy through a deeper understanding of their mechanisms and interactions.